DR. KELLY & PARTNERS
Vere Foster Medical Group, Vere Foster Medical Group, 132-136 Sandy Row, BELFASTSTIA007NI
The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 15 months that an anti-platelet agent, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 11 | 15 | 73.3% | |
STROKE 9 | 2006 | 29 | 32 | 90.6% | |
Stroke 12 | 2007 | 41 | 42 | 97.6% | |
Stroke 12 | 2008 | 49 | 51 | 96.1% | |
Stroke 12 | 2009 | 51 | 55 | 92.7% | |
Stroke 12 | 2010 | 45 | 52 | 86.5% | |
STROKE 12 | 2011 | 56 | 60 | 93.3% | |
STROKE 12 | 2012 | 56 | 59 | 94.9% | |
STROKE 12 | 2013 | 59 | 63 | 93.7% | |
STIA007NI | 2014 | 57 | 62 | 91.9% | |
STIA007 | 2015 | 69 | 77 | 89.6% | |
STIA007 | 2016 | 75 | 82 | 91.5% | |
STIA007 | 2017 | 74 | 80 | 92.5% | |
STIA007 | 2018 | 70 | 77 | 90.9% | |
STIA007 | 2019 | 72 | 79 | 91.1% | |
STIA007 | 2020 | 73 | 83 | 88.0% | |
STIA007 | 2021 | 78 | 91 | 85.7% |